In this chapter, we focus on phosphomodifications of ERα in tumor cells that, by themselves, do not affect the female hormone estradiol (E2) dependency of the tumor cells for proliferation, but could affect the response to tamoxifen. The gene discussed is ESR1; the disease is neoplasm.